Suscribe to our Newsletter

martes, 21 de mayo de 2013

"Rapamycin derivatives for treating cancer", Special Topic Issue in Translational Biomedicine


Call for Papers: 

"Rapamycin derivatives for treating cancer", Special Topic Issue in Translational Biomedicine

Dear colleague:
It is my pleasure to let you know I have been designated as Guest Editor to edit an special topic issue in Translational Biomedicine (ISSN: 2172-0479)
Translational Biomedicine is indexed in Journal TOC, Open J-Gate, Google Scholar, Open Archives Harvester, Academic Search Complete, JournalSeek, Electronic Journals Library of University Library, EBSCO, Index Copernicus Master List, Research and Markets, Embase, Scopus and Timbó.

It will be focused in "Rapamycin derivatives for treating cancer". This issue aims to disseminate investigations on the autonomic nervous system and its relationship with the cardiovascular system. 

Rapamycin derivatives have been approved for several types of cancers. However, the mechanism underlying their effects on inhibiting tumor growth is not well understood. Moreover, the side effect of rapamycin derivatives has been a huge concern, as long term administration causes myelosuppression, hyperlipidemia, insulin resistance etc. Therefore, research focusing on cellular signaling that modulated by rapamycin and clinical evaluation of its derivatives in related diseases has recently drawn broad interest, as such research promises to provide knowledge for developing new drugs that have increased efficacy while minimized side effect. In this special thematic issue, we would like to call for research articles, review articles, case reports, short communications from basic sciences that involve cellular and molecular studies on the target of rapamycin (TOR or mTOR) pathway, as well as clinical sciences regarding every aspects of rapamycin derivative.

The main types of contribution are full-length articles, short communications and review articles.
The articles published are subjected to iMedPub's article processing charges. This charges are, by far, the lowest article processing charges of all medical publishers.

I hope we can count with your contributions soon. Deadline is 30th August. You can submit online here. Please, in the first step "Comments" write "This manuscript is for for the special issue Rapamycin derivatives for treating cancer". Looking forward to receive your manuscripts.

Best wishes
Yuehua Wei Ph.D.

Department of Biochemistry and Biophysics,
University of California, San Francisco,
600 16th St, Room S314, Box 2200,
San Francisco, CA 94158-2517, USA
Phone: (415)-476-9864
Fax; (415)-514-4145

The Headhunter 
Are you interested in medical publishing? Join us! social network Join now! Subscribe now!


No hay comentarios:

Publicar un comentario